Pfizer Neurontin Neuropathic Pain NDA Planned; Relpax Awaits New Study

Pfizer is preparing an NDA supplement for Neurontin that could allow open marketing of gabapentin for neuropathic pain indications.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet